• Dec 04, 2006 | Webcast

    Final Comments

    Anthony Norman, Ph.D., Hector DeLuca, Ph.D., Murray Favus, M.D., Lawrence Raisz, M.D., Roger Bouillon, M.D., Ph.D., Craig Langman, M.D., David Goltzman, M.D.
    Investigation of Metabolic Bone Diseases, Metabolic Bone Diseases, Integrative Physiology of the Skeleton

    Anthony Norman, Ph.D.
    University of California, USA

    Hector DeLuca, Ph.D.
    University of Wisconsin, Madison, USA

    Murray Favus, M.D.
    University of Chicago, USA

    Lawrence Raisz, M.D.
    University of Connecticut Health Center, USA

    Roger Bouillon, M.D., Ph.D.
    Katholieke Universiteit Leuven, Belgium

    Craig Langman, M.D.
    Ann & Robert H Lurie Childrens Hospital of Chicago, USA

    David Goltzman, M.D.
    McGill University, Canada

    Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.

    Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    Length: 60 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details